The effect of acetazolamide on cognitive function in hypoxia
Phase 3
Recruiting
- Conditions
- ormobaric hypoxia.
- Registration Number
- IRCT20170326033146N5
- Lead Sponsor
- Razi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 14
Inclusion Criteria
Male student of Razi University
Age 18 to 29 years old
BMI: 18.5 - 29.4
Exclusion Criteria
Permanent residence at altitudes above 2000 meters
History of cognitive disorders or neurological diseases
Having a chronic illness
Smoking
History of living at altitudes of more than 2000 meters in the two months before the start of a research
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Simple visual reaction time. Timepoint: The beginning of the study to assess the level of cognitive function after taking acetazolamide or placebo and after hypoxia. Method of measurement: Cognitive function is assessed using a reaction time device. ( RESPONSE PANEL63035A, LAFAYETTE, INDIANA ).;Simple auditory reaction time. Timepoint: The beginning of the study to assess the level of cognitive function after taking acetazolamide or placebo and after hypoxia. Method of measurement: Cognitive function is assessed using a reaction time device. ( RESPONSE PANEL63035A, LAFAYETTE, INDIANA ).;Selective visual reaction time. Timepoint: The beginning of the study to assess the level of cognitive function after taking acetazolamide or placebo and after hypoxia. Method of measurement: Cognitive function is assessed using a reaction time device. ( RESPONSE PANEL63035A, LAFAYETTE, INDIANA ).
- Secondary Outcome Measures
Name Time Method